UNCLAIMED
Pacira
Overview
Pacira is a U.S.-based company founded in 2006, operating within the pharmaceuticals and biotechnology sectors of the manufacturing industry. With a workforce of 501 to 1,000 employees, the company specializes in developing non-opioid pain management solutions, particularly in the context of surgical procedures such as total knee arthroplasty (TKA) and total hip arthroplasty (THA). Their published documents indicate a focus on the economic implications of using liposomal bupivacaine (LB) in outpatient settings, highlighting its role in reducing opioid consumption and improving patient outcomes post-surgery. Research reports and technical documents detail real-world data analysis on healthcare costs and resource utilization associated with LB use compared to traditional pain management methods. The company emphasizes the importance of effective perioperative pain control to enhance recovery and minimize complications, as evidenced by their studies on opioid consumption and healthcare resource utilization metrics. Overall, Pacira's expertise lies in advancing multimodal analgesic strategies to improve patient care in surgical settings.